US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Seaport Therapeutics

18.15

+0.24001.34%

Post-market: 18.150.00000.00%16:10 EDT

Volume:171.21K

Turnover:3.11M

Market Cap:971.58M

PE:-7.21

High:18.79

Open:18.00

Low:17.89

Close:17.91

52wk High:28.38

52wk Low:14.85

Shares:53.53M

Float Shares:14.16M

Volume Ratio:0.78

T/O Rate:1.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5160

EPS(LYR):-10.0430

ROE:-28.08%

ROA:-18.90%

PB:2.30

PE(LYR):-1.81

Loading ...

Overview Company News Filings

Top Insider Just Boosted Stake in Seaport Therapeutics With a Bold Buy

Seaport Therapeutics Director Robert J. Hombach Trust Buys 13,000 Shares Worth $235,768

Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)

Seaport Therapeutics Q1 Net Loss Widens

MT Newswires Live

Seaport Therapeutics Q1 EPS $(10.34) Misses $(9.48) Estimate

Benzinga Earnings

Seaport Therapeutics reports Q1 EPS ($10.34) vs. ($5.65) last year

Seaport Therapeutics sees cash runway into 2029

Earnings Flash (SPTX) Seaport Therapeutics Posts Q1 Net Loss $10.34 a Share, vs. FactSet Est of $10.64 Loss

MT Newswires Live

Seaport Therapeutics - Q1 Net Loss per Share $10.34

THOMSON REUTERS

Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

THOMSON REUTERS

Seaport Therapeutics - Seven-Day Glyphago Dosing Achieves Therapeutic Agomelatine Exposures Without Liver Enzyme Elevations

THOMSON REUTERS

Seaport Therapeutics - to Initiate Phase 2B Glyphago Trial in First Half of 2027

THOMSON REUTERS

Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data From Phase 1 Proof-of-Concept Trial of Glyphago™ in Healthy Volunteers

THOMSON REUTERS

Seaport Therapeutics - Repeat Dosing of Glyphago Shows Favorable Safety and No Liver-Related Adverse Events

THOMSON REUTERS

Citi Sticks to Its Buy Rating for Seaport Therapeutics, Inc. (SPTX)

Seaport Therapeutics to Present at Two Major Investor Conferences, Highlighting Neuropsychiatric Drug Development

Seaport Therapeutics to present at Goldman Sachs Global Healthcare Conference

Seaport Therapeutics Initiated at Buy by Stifel

Stifel Initiates Seaport Therapeutics at Buy With $30 Price Target

MT Newswires Live

Seaport Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $30

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/SPTX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPTX\",,,,,undefined,":{"symbol":"SPTX","market":"US","secType":"STK","nameCN":"Seaport Therapeutics","latestPrice":18.15,"timestamp":1791576000000,"preClose":17.91,"halted":0,"volume":171205,"hourTrading":{"tag":"盘后","latestPrice":18.15,"preClose":18.15,"latestTime":"16:10 EDT","volume":217,"amount":3938.5499999999997,"timestamp":1791576604170,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.013400335008375123,"floatShares":14160000,"shares":53530550,"eps":-2.516,"marketStatus":"Post-Mkt","change":0.24,"latestTime":"10-09 17:21:50 EDT","open":18,"high":18.79,"low":17.89,"amount":3113219,"amplitude":0.050251,"askPrice":21.48,"askSize":160,"bidPrice":17.92,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-2.516,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"listingDate":1777608000000,"exchange":"NASDAQ","adjPreClose":17.91,"postHourTrading":{"tag":"盘后","latestPrice":18.15,"preClose":18.15,"latestTime":"16:10 EDT","volume":217,"amount":3938.5499999999997,"timestamp":1791576604170,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.777532},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPTX\",,,,,undefined,":{"symbol":"SPTX","floatShares":14160000,"roa":"-18.90%","roe":"-28.08%","lyrEps":-10.043037,"volumeRatio":0.777532,"shares":53530550,"dividePrice":0,"high":18.79,"amplitude":0.050251,"preClose":17.91,"low":17.89,"week52Low":14.85,"pbRate":"2.30","week52High":28.3833,"institutionHeld":0,"latestPrice":18.15,"committee":-0.987578,"eps":-2.516,"divideRate":0,"volume":171205,"delay":0,"ttmEps":-2.516,"open":18,"prevYearClose":18,"prevWeekClose":18.42,"prevMonthClose":20.17,"prevQuarterClose":20.17,"fiveDayClose":18.42,"twentyDayClose":23.34,"sixtyDayClose":19.52},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"SPTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.71,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"pre","actualEps":-1.78}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.375,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1790395200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPTX","date":"2026-10-08","current":-7.213831,"percent":0.990741,"low":-14.505892,"twenty":-12.644435,"median":-11.330579,"eighty":-9.343911,"high":-6.903604,"avg":-11.032351,"sd":1.844446,"marketCap":959802761},"quantilePoints":[{"date":"2026-05-08","current":-10.976498,"twenty":-12.440976,"median":-11.330579,"eighty":-11.259763,"marketCap":821931163},{"date":"2026-05-15","current":-11.99625,"twenty":-12.004748,"median":-11.348283,"eighty":-11.231436,"marketCap":898291219},{"date":"2026-05-22","current":-12.173291,"twenty":-12.004748,"median":-11.330579,"eighty":-11.135126,"marketCap":911548174},{"date":"2026-05-29","current":-13.31343,"twenty":-12.537286,"median":-11.684659,"eighty":-11.163453,"marketCap":996922959},{"date":"2026-06-05","current":-12.661922,"twenty":-12.698746,"median":-12.017495,"eighty":-11.247016,"marketCap":948137367},{"date":"2026-06-12","current":-12.548616,"twenty":-12.593938,"median":-12.03874,"eighty":-11.316416,"marketCap":939652917},{"date":"2026-06-18","current":-10.501726,"twenty":-12.6166,"median":-12.03874,"eighty":-11.222938,"marketCap":915372405},{"date":"2026-06-26","current":-11.889673,"twenty":-12.53162,"median":-11.895161,"eighty":-11.165224,"marketCap":1036351448},{"date":"2026-07-02","current":-13.173217,"twenty":-12.752567,"median":-12.017495,"eighty":-11.198861,"marketCap":1148230297},{"date":"2026-07-10","current":-12.595929,"twenty":-12.752567,"median":-12.03874,"eighty":-11.215593,"marketCap":1097911580},{"date":"2026-07-17","current":-11.987935,"twenty":-12.752567,"median":-12.12726,"eighty":-11.302253,"marketCap":1044916336},{"date":"2026-07-24","current":-13.474144,"twenty":-12.866109,"median":-12.187454,"eighty":-11.330579,"marketCap":1174460267},{"date":"2026-07-31","current":-12.479243,"twenty":-12.804736,"median":-12.201617,"eighty":-11.330579,"marketCap":1087740776},{"date":"2026-08-07","current":-14.1804,"twenty":-12.896856,"median":-12.347233,"eighty":-11.365987,"marketCap":1236020399},{"date":"2026-08-14","current":-9.423399,"twenty":-12.896856,"median":-12.221306,"eighty":-11.295171,"marketCap":1269209340},{"date":"2026-08-21","current":-9.552568,"twenty":-12.881452,"median":-12.180373,"eighty":-11.146457,"marketCap":1286606769},{"date":"2026-08-28","current":-10.432907,"twenty":-12.804736,"median":-12.123719,"eighty":-11.036024,"marketCap":1405176937},{"date":"2026-09-04","current":-9.653917,"twenty":-12.782309,"median":-12.017495,"eighty":-10.432907,"marketCap":1300257059},{"date":"2026-09-11","current":-9.252498,"twenty":-12.759648,"median":-11.944292,"eighty":-9.835946,"marketCap":1246191204},{"date":"2026-09-18","current":-8.67223,"twenty":-12.748317,"median":-11.889673,"eighty":-9.660275,"marketCap":1168036601},{"date":"2026-09-25","current":-8.394019,"twenty":-12.694907,"median":-11.667409,"eighty":-9.560914,"marketCap":1130565216},{"date":"2026-10-02","current":-7.531565,"twenty":-12.665919,"median":-11.472211,"eighty":-9.452015,"marketCap":1014403922},{"date":"2026-10-08","current":-7.126172,"twenty":-12.644435,"median":-11.330579,"eighty":-9.343911,"marketCap":959802761}],"updateTime":1791580910585},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPTX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2646823822","title":"Top Insider Just Boosted Stake in Seaport Therapeutics With a Bold Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2646823822","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646823822?lang=en_us&edition=fundamental","pubTime":"2026-06-25 10:04","pubTimestamp":1782353050,"startTime":"0","endTime":"0","summary":"New insider activity at Seaport Therapeutics, Inc. ( ($SPTX) ) has taken place on June 24, 2026. Director Robert Hombach has increased his stake in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-insider-just-boosted-stake-in-seaport-therapeutics-with-a-bold-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-insider-just-boosted-stake-in-seaport-therapeutics-with-a-bold-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645463891","title":"Seaport Therapeutics Director Robert J. Hombach Trust Buys 13,000 Shares Worth $235,768","url":"https://stock-news.laohu8.com/highlight/detail?id=2645463891","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645463891?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:05","pubTimestamp":1782295548,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics director Robert J. Hombach trust buys 13,000 shares worth $235,768Seaport Therapeutics director Robert J. Hombach reported an indirect purchase of 13,000 common shares.The shares ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL752g0n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Seaport Therapeutics Director Robert J. Hombach Trust Buys 13,000 Shares Worth $235,768","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642249886","title":"Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642249886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642249886?lang=en_us&edition=fundamental","pubTime":"2026-06-09 21:01","pubTimestamp":1781010094,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Alamar Biosciences, Inc. (ALMR) and Seaport Therapeutics, In...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-alamar-biosciences-inc-almr-seaport-therapeutics-inc-sptx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-alamar-biosciences-inc-almr-seaport-therapeutics-inc-sptx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPTX","BK4112","NA","ALMR","BLSX","BLSG","BK4007","BK4121","BLSH","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641194489","title":"Seaport Therapeutics Q1 Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2641194489","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641194489?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:32","pubTimestamp":1780918324,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics  reported Monday its Q1 net loss widened to $10.34 per diluted share, compared with a loss of $5.65 a year earlier.Two analysts polled by FactSet expected a loss of $10.64.Cash, cash equivalents, and investments totaled $212.6 million as of March 31, which along with its initial public offering proceeds are expected to fund operations into 2029, the company said. Seaport said it raised $260 million in gross proceeds from its IPO in May.Shares of Seaport were up 3.8% in premarket activity Monday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641489546","title":"Seaport Therapeutics Q1 EPS $(10.34) Misses $(9.48) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2641489546","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641489546?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:22","pubTimestamp":1780917762,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics (NASDAQ:SPTX) reported quarterly losses of $(10.34) per share which missed the analyst consensus estimate of $(9.48) by 9.07 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/06/53053637/seaport-therapeutics-q1-eps-10-34-misses-9-48-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641374489","title":"Seaport Therapeutics reports Q1 EPS ($10.34) vs. ($5.65) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2641374489","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641374489?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:18","pubTimestamp":1780917532,"startTime":"0","endTime":"0","summary":"“The first quarter of 2026 was filled with meaningful progress for Seaport, and we significantly advanced the clinical development of our lead Glyp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-reports-q1-eps-10-34-vs-5-65-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-reports-q1-eps-10-34-vs-5-65-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641489568","title":"Seaport Therapeutics sees cash runway into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2641489568","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641489568?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:17","pubTimestamp":1780917470,"startTime":"0","endTime":"0","summary":"Cash, cash equivalents, and investments totaled $212.6 million as of March 31, 2026. Subsequent to March 31, 2026, Seaport completed its IPO, in wh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-sees-cash-runway-into-2029-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-sees-cash-runway-into-2029-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","IPOS","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486206","title":"Earnings Flash (SPTX) Seaport Therapeutics Posts Q1 Net Loss $10.34 a Share, vs. FactSet Est of $10.64 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486206","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486206?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:09","pubTimestamp":1780916971,"startTime":"0","endTime":"0","summary":"Earnings Flash (SPTX) Seaport Therapeutics Posts Q1 Net Loss $10.34 a Share, vs. FactSet Est of $10.64 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641864744","title":"Seaport Therapeutics - Q1 Net Loss per Share $10.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2641864744","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641864744?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:05","pubTimestamp":1780916700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA2FRLJF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641861724","title":"Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2641861724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641861724?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:05","pubTimestamp":1780916700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA2FRLJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641609486","title":"Seaport Therapeutics - Seven-Day Glyphago Dosing Achieves Therapeutic Agomelatine Exposures Without Liver Enzyme Elevations","url":"https://stock-news.laohu8.com/highlight/detail?id=2641609486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641609486?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486953","title":"Seaport Therapeutics - to Initiate Phase 2B Glyphago Trial in First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486953?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486939","title":"Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data From Phase 1 Proof-of-Concept Trial of Glyphago™ in Healthy Volunteers","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486939?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486675","title":"Seaport Therapeutics - Repeat Dosing of Glyphago Shows Favorable Safety and No Liver-Related Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486675?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640966895","title":"Citi Sticks to Its Buy Rating for Seaport Therapeutics, Inc. (SPTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640966895","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640966895?lang=en_us&edition=fundamental","pubTime":"2026-06-02 01:15","pubTimestamp":1780334118,"startTime":"0","endTime":"0","summary":"Citi analyst Yigal Nochomovitz maintained a Buy rating on Seaport Therapeutics, Inc. today and set a price target of $35.00. Nochomovitz covers the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-its-buy-rating-for-seaport-therapeutics-inc-sptx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-sticks-to-its-buy-rating-for-seaport-therapeutics-inc-sptx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105741779","title":"Seaport Therapeutics to Present at Two Major Investor Conferences, Highlighting Neuropsychiatric Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1105741779","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105741779?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:10","pubTimestamp":1780319430,"startTime":"0","endTime":"0","summary":"Clinical-stage biopharmaceutical company Seaport Therapeutics, which focuses on novel treatments for neuropsychiatric disorders, has announced that its management team will participate in two...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","SPTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640955900","title":"Seaport Therapeutics to present at Goldman Sachs Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2640955900","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640955900?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:01","pubTimestamp":1780311677,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics will join the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026, featuring an 8:00 a.m. EDT fireside chat.Management will also participate in UBS Virtual CNS Day on June 15, 2026, with a 10:00 a.m. EDT fireside chat.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seaport Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on June 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL53vx61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868837300.USD","LU2471134952.CNY","LU0868494617.USD","LU1894683348.USD","BK4504","BK4588","LU0345770993.USD","LU2237443549.SGD","IE0004086264.USD","BK4552","IE0002270589.USD","LU0742534661.SGD","BK4585","LU0048573561.USD","LU1868836914.USD","LU2750360997.AUD","LU0868494708.USD","BK4516","LU0096364046.USD","LU1868837136.USD","LU1791807156.HKD","IE0004091025.USD","LU2471134879.HKD","BK4550","LU1894683264.USD","GSX","LU2237443978.SGD","LU2471134523.USD","LU2750360641.GBP","LU2265009873.SGD","SPTX","LU1868836591.USD","LU1804176565.USD","LU2237443465.HKD","BK4127","LU2237438978.USD","LU2237443622.USD","LU0251142724.SGD","IE00BSNM7G36.USD","BK4007","LU1868836757.USD","LU2471134796.USD","LU2237443382.USD","LU1668664300.SGD","IE0034235188.USD","IE00BFXG1179.USD","LU0251131958.USD","LU0942090050.USD","IE00B19Z3B42.SGD","LU0345770308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638954607","title":"Seaport Therapeutics Initiated at Buy by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2638954607","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638954607?lang=en_us&edition=fundamental","pubTime":"2026-05-27 00:11","pubTimestamp":1779811860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SPTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 26, 2026 12:11 ET (16:11 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX","SF","BK4007","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638511679","title":"Stifel Initiates Seaport Therapeutics at Buy With $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2638511679","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638511679?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:47","pubTimestamp":1779796045,"startTime":"0","endTime":"0","summary":"(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPTX","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638515068","title":"Seaport Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2638515068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638515068?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:46","pubTimestamp":1779792377,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nFWN42306X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":73,"code":"91000000","status":"200"}]}}